Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1977 | 1 |
2017 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Bevacizumab for Metastatic Colorectal Cancer: A Global Cost-Effectiveness Analysis.
Oncologist. 2017 Jun;22(6):694-699. doi: 10.1634/theoncologist.2016-0455. Epub 2017 Jun 7.
Oncologist. 2017.
PMID: 28592621
Free PMC article.
Our objective was to establish the cost-effectiveness of bevacizumab in mCRC in the U.S., U.K., Canada, Australia, and Israel. METHODS: We performed the analysis using a previously established Markov model for mCRC. ...By conventional thresholds, bevacizumab is not cost-ef …
Our objective was to establish the cost-effectiveness of bevacizumab in mCRC in the U.S., U.K., Canada, Australia, and Israel. METHOD …
Red cell metabolism and severe neonatal jaundice in West Malaysia.
Lie-Injo LE, Virik HK, Lim PW, Lie AK, Ganesan J.
Lie-Injo LE, et al.
Acta Haematol. 1977;58(3):152-60. doi: 10.1159/000207822.
Acta Haematol. 1977.
PMID: 409030
Among the Malay infants, 10 (17.2%) had G6PD deficiency, 7 (12.1%) had Hb Bart's and 10 (17.2%) had abnormal haemoglobins (four had Hb E trait, one had Hb K and Bart's in addition to Hb E, three had Hb CoSp with Hb Bart's, one had Hb Q and one Hb Tak). ...
Among the Malay infants, 10 (17.2%) had G6PD deficiency, 7 (12.1%) had Hb Bart's and 10 (17.2%) had abnormal haemoglobins (four had Hb E tra …
Item in Clipboard
Cite
Cite